comparemela.com

Latest Breaking News On - Allovir daily - Page 1 : comparemela.com

Head to Head Comparison: AlloVir (NASDAQ:ALVR) and Senti Biosciences (NASDAQ:SNTI)

Head to Head Comparison: AlloVir (NASDAQ:ALVR) and Senti Biosciences (NASDAQ:SNTI)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Waltham
Massachusetts
United-states
California
South-san-francisco
Senti-biosciences-inc
Celest-therapeutics-shanghai-co
Allovir-inc
Viracyte-inc
Get-free-report
Senti-biosciences

Contrasting AlloVir (NASDAQ:ALVR) & Acumen Pharmaceuticals (NASDAQ:ABOS)

Contrasting AlloVir (NASDAQ:ALVR) & Acumen Pharmaceuticals (NASDAQ:ABOS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Waltham
Charlottesville
Virginia
Acumen-pharmaceuticals
Acumen-pharmaceuticals-inc
Viracyte-inc
Allovir-inc
Get-free-report
Acumen-pharmaceutical

AlloVir, Inc. (NASDAQ:ALVR) Given Average Rating of "Reduce" by Brokerages

AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) has been assigned a consensus rating of “Reduce” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, three have given a hold recommendation and one has assigned a buy recommendation to the company. The […]

United-states
America
Leerink-partnrs
Diana-brainard
Piper-sandler
Nasdaq
Jpmorgan-chase-co
Vanguard-group-inc
Capital-partners
Barclays-plc
Goldman-sachs-group-inc
Allovir-inc

AlloVir, Inc. (NASDAQ:ALVR) CEO Sells $27,752.07 in Stock

AlloVir, Inc. (NASDAQ:ALVR) CEO Sells $27,752.07 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Piper-sandler
Leerink-partnrs
Diana-brainard
Allovir-company-profile
Nasdaq
Jpmorgan-chase-co
Allovir-inc
Blackrock-inc
Artal-group
Vanguard-group-inc

Analysts Set AlloVir, Inc. (NASDAQ:ALVR) PT at $18.75

Shares of AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) have received an average recommendation of “Reduce” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the […]

United-states
America
Piper-sandler
Leerink-partnrs
Metlife-investment-management
Nasdaq
Allovir-company-profile
Charles-schwab-investment-management-inc
Jpmorgan-chase-co
Ensign-peak-advisors-inc
Allovir-inc
Get-free-report

vimarsana © 2020. All Rights Reserved.